ImmPACT Bio Appoints Biren Amin, M.B.A. to its Board of Directors
Seasoned executive brings decades of experience in capital markets, finance, and corporate strategy WEST HILLS, Calif., February 8, 2023 — ImmPACT Bio USA, Inc. (“ImmPACT Bio”), a clinical-stage company developing transformative logic-gate-based chimeric antigen receptor (CAR) T-cell therapies for treating cancer, today announced the appointment of Biren Amin, M.B.A., to its board of directors. Mr. […]
